Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1990 Nov;45(11):825–830. doi: 10.1136/thx.45.11.825

Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

N S Morton
PMCID: PMC462776  PMID: 2256008

Full text

PDF
825

Images in this article

826Image
on p.826

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVERY M. E., MEAD J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959 May;97(5 Pt 1):517–523. doi: 10.1001/archpedi.1959.02070010519001. [DOI] [PubMed] [Google Scholar]
  2. Ashbaugh D. G., Bigelow D. B., Petty T. L., Levine B. E. Acute respiratory distress in adults. Lancet. 1967 Aug 12;2(7511):319–323. doi: 10.1016/s0140-6736(67)90168-7. [DOI] [PubMed] [Google Scholar]
  3. Bahrami S., Strohmaier W., Redl H., Schlag G. Mechanical properties of the lungs of posttraumatic rats are improved by including fat in total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1987 Nov-Dec;11(6):560–565. doi: 10.1177/0148607187011006560. [DOI] [PubMed] [Google Scholar]
  4. Barrowcliffe M. P., Otto C., Jones J. G. Pulmonary clearance of 99mTc-DTPA: influence of background activity. J Appl Physiol (1985) 1988 Mar;64(3):1045–1049. doi: 10.1152/jappl.1988.64.3.1045. [DOI] [PubMed] [Google Scholar]
  5. Berry D., Ikegami M., Jobe A. Respiratory distress and surfactant inhibition following vagotomy in rabbits. J Appl Physiol (1985) 1986 Nov;61(5):1741–1748. doi: 10.1152/jappl.1986.61.5.1741. [DOI] [PubMed] [Google Scholar]
  6. CLEMENTS J. A., BROWN E. S., JOHNSON R. P. Pulmonary surface tension and the mucus lining of the lungs: some theoretical considerations. J Appl Physiol. 1958 Mar;12(2):262–268. doi: 10.1152/jappl.1958.12.2.262. [DOI] [PubMed] [Google Scholar]
  7. Comroe J. H., Jr Premature science and immature lungs. Part I. Some premature discoveries. Am Rev Respir Dis. 1977 Jul;116(1):127–135. doi: 10.1164/arrd.1977.116.1.127. [DOI] [PubMed] [Google Scholar]
  8. Comroe J. H., Jr Premature science and immature lungs. Part III. The attack on immature lungs. Am Rev Respir Dis. 1977 Sep;116(3):497–518. doi: 10.1164/arrd.1977.116.3.497. [DOI] [PubMed] [Google Scholar]
  9. Disse B. G. The pharmacology of ambroxol--review and new results. Eur J Respir Dis Suppl. 1987;153:255–262. [PubMed] [Google Scholar]
  10. Dobbs L. G., Wright J. R., Hawgood S., Gonzalez R., Venstrom K., Nellenbogen J. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci U S A. 1987 Feb;84(4):1010–1014. doi: 10.1073/pnas.84.4.1010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Enhörning G., Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics. 1972 Jul;50(1):58–66. [PubMed] [Google Scholar]
  12. Evander E., Wollmer P., Jonson B., Lachmann B. Pulmonary clearance of inhaled 99mTc-DTPA: effects of surfactant depletion by lung lavage. J Appl Physiol (1985) 1987 Apr;62(4):1611–1614. doi: 10.1152/jappl.1987.62.4.1611. [DOI] [PubMed] [Google Scholar]
  13. Fein A. M., Goldberg S. K., Lippmann M. L., Fischer R., Morgan L. Adult respiratory distress syndrome. Br J Anaesth. 1982 Jul;54(7):723–736. doi: 10.1093/bja/54.7.723. [DOI] [PubMed] [Google Scholar]
  14. Floros J., Phelps D. S., Taeusch H. W. Biosynthesis and in vitro translation of the major surfactant-associated protein from human lung. J Biol Chem. 1985 Jan 10;260(1):495–500. [PubMed] [Google Scholar]
  15. Fuchimukai T., Fujiwara T., Takahashi A., Enhorning G. Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol (1985) 1987 Feb;62(2):429–437. doi: 10.1152/jappl.1987.62.2.429. [DOI] [PubMed] [Google Scholar]
  16. Hamilton P. P., Onayemi A., Smyth J. A., Gillan J. E., Cutz E., Froese A. B., Bryan A. C. Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol Respir Environ Exerc Physiol. 1983 Jul;55(1 Pt 1):131–138. doi: 10.1152/jappl.1983.55.1.131. [DOI] [PubMed] [Google Scholar]
  17. Hawgood S., Benson B. J., Hamilton R. L., Jr Effects of a surfactant-associated protein and calcium ions on the structure and surface activity of lung surfactant lipids. Biochemistry. 1985 Jan 1;24(1):184–190. doi: 10.1021/bi00322a026. [DOI] [PubMed] [Google Scholar]
  18. Hills B. A. Bursting the alveolar bubble. Anaesthesia. 1987 May;42(5):467–469. doi: 10.1111/j.1365-2044.1987.tb04035.x. [DOI] [PubMed] [Google Scholar]
  19. Hollingsworth M., Gilfillan A. M. The pharmacology of lung surfactant secretion. Pharmacol Rev. 1984 Jun;36(2):69–90. [PubMed] [Google Scholar]
  20. Holm B. A., Enhorning G., Notter R. H. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity. Chem Phys Lipids. 1988 Nov;49(1-2):49–55. doi: 10.1016/0009-3084(88)90063-1. [DOI] [PubMed] [Google Scholar]
  21. Holm B. A., Matalon S., Finkelstein J. N., Notter R. H. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol (1985) 1988 Dec;65(6):2672–2678. doi: 10.1152/jappl.1988.65.6.2672. [DOI] [PubMed] [Google Scholar]
  22. Holm B. A., Matalon S. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome. Anesth Analg. 1989 Dec;69(6):805–818. [PubMed] [Google Scholar]
  23. Holm B. A., Notter R. H. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol (1985) 1987 Oct;63(4):1434–1442. doi: 10.1152/jappl.1987.63.4.1434. [DOI] [PubMed] [Google Scholar]
  24. Holm B. A., Notter R. H., Siegle J., Matalon S. Pulmonary physiological and surfactant changes during injury and recovery from hyperoxia. J Appl Physiol (1985) 1985 Nov;59(5):1402–1409. doi: 10.1152/jappl.1985.59.5.1402. [DOI] [PubMed] [Google Scholar]
  25. Hunter D. N., Keogh B. F., Morgan C. J., Evans T. W. The management of adult respiratory distress syndrome: 1. Br J Hosp Med. 1989 Dec;42(6):468–471. [PubMed] [Google Scholar]
  26. Ikegami M., Jobe A. H., Pettenazzo A., Seidner S. R., Berry D. D., Ruffini L. Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis. 1987 Oct;136(4):892–898. doi: 10.1164/ajrccm/136.4.892. [DOI] [PubMed] [Google Scholar]
  27. Jobe A., Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis. 1987 Nov;136(5):1256–1275. doi: 10.1164/ajrccm/136.5.1256. [DOI] [PubMed] [Google Scholar]
  28. Lachmann B., Hallman M., Bergmann K. C. Respiratory failure following anti-lung serum: study on mechanisms associated with surfactant system damage. Exp Lung Res. 1987;12(2):163–180. doi: 10.3109/01902148709062839. [DOI] [PubMed] [Google Scholar]
  29. Lachmann B., Robertson B., Vogel J. In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand. 1980 Jun;24(3):231–236. doi: 10.1111/j.1399-6576.1980.tb01541.x. [DOI] [PubMed] [Google Scholar]
  30. Lisi D. M. Muscle spasms and creatine phosphokinase elevation following salbutamol administration. Eur Respir J. 1989 Jan;2(1):98–98. [PubMed] [Google Scholar]
  31. Loewen G. M., Holm B. A., Milanowski L., Wild L. M., Notter R. H., Matalon S. Alveolar hyperoxic injury in rabbits receiving exogenous surfactant. J Appl Physiol (1985) 1989 Mar;66(3):1087–1092. doi: 10.1152/jappl.1989.66.3.1087. [DOI] [PubMed] [Google Scholar]
  32. Marks L. B., Notter R. H., Oberdorster G., McBride J. T. Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity. Pediatr Res. 1983 Sep;17(9):742–747. doi: 10.1203/00006450-198309000-00012. [DOI] [PubMed] [Google Scholar]
  33. Mason R. J. Surfactant in adult respiratory distress syndrome. Eur J Respir Dis Suppl. 1987;153:229–236. [PubMed] [Google Scholar]
  34. Matalon S., Holm B. A., Notter R. H. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J Appl Physiol (1985) 1987 Feb;62(2):756–761. doi: 10.1152/jappl.1987.62.2.756. [DOI] [PubMed] [Google Scholar]
  35. Morton N. S. Pulmonary surfactant: physiology, pharmacology and clinical uses. Br J Hosp Med. 1989 Jul;42(1):52–58. [PubMed] [Google Scholar]
  36. Petty T. L., Ashbaugh D. G. The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management. Chest. 1971 Sep;60(3):233–239. doi: 10.1378/chest.60.3.233. [DOI] [PubMed] [Google Scholar]
  37. Petty T. L., Silvers G. W., Paul G. W., Stanford R. E. Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest. 1979 May;75(5):571–574. doi: 10.1378/chest.75.5.571. [DOI] [PubMed] [Google Scholar]
  38. Seeger W., Stöhr G., Wolf H. R., Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol (1985) 1985 Feb;58(2):326–338. doi: 10.1152/jappl.1985.58.2.326. [DOI] [PubMed] [Google Scholar]
  39. Van Golde L. M., Batenburg J. J., Robertson B. The pulmonary surfactant system: biochemical aspects and functional significance. Physiol Rev. 1988 Apr;68(2):374–455. doi: 10.1152/physrev.1988.68.2.374. [DOI] [PubMed] [Google Scholar]
  40. White R. T., Damm D., Miller J., Spratt K., Schilling J., Hawgood S., Benson B., Cordell B. Isolation and characterization of the human pulmonary surfactant apoprotein gene. 1985 Sep 26-Oct 2Nature. 317(6035):361–363. doi: 10.1038/317361a0. [DOI] [PubMed] [Google Scholar]
  41. Witschi H. R., Haschek W. M., Klein-Szanto A. J., Hakkinen P. J. Potentiation of diffuse lung damage by oxygen: determining variables. Am Rev Respir Dis. 1981 Jan;123(1):98–103. doi: 10.1164/arrd.1981.123.1.98. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES